Genomic Health Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 8, this is below the company average, and notable indication of worsening business environment. Average collection period, for Genomic Health Inc's accounts receivable remained unchanged at 46 days, in the Sep 30 2019 quarter.

If we take a look into Healthcare sector 174 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2019 from 934 to 1700.

What is Receivable Turnover Ratio?
What is Genomic Health Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GHDX Receivables Turnover Ratio	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter
Y / Y Receivable Change	8.38 %	10.87 %	27.23 %	65.37 %	44.88 %
Y / Y Revenue Change	12.93 %	19.37 %	17.43 %	19.6 %	20.8 %
Receivable Turnover Ratio (TTM)	8	7.92	7.77	7.94	8.46
GHDX's Total Ranking	# 1700	# 934	# 934	# 1629	# 1504
Accounts Receivable average collection period days	46	46	47	46	43
Seq. Receivable Change	2.89 %	-8.34 %	14.98 %	-0.04 %	5.25 %
Seq. Revenue Change	0.19 %	4.94 %	3.98 %	3.31 %	5.9 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 11
Healthcare Sector	# 175
Overall Market	# 1700

Receivable Turnover Ratio Statistics
High	Average	Low
10.19	8.83	7.77
(Dec 31 2017)		(Mar 31 2019)

GHDX Company Profile • Back to GHDX Efficiency Comparisons • Compare GHDX Receivables Turnover Ratio to its Competitors

Financial Statements
Genomic Health Inc's Accounts Receivable	$ 56 Millions	Visit GHDX's Balance sheet
Genomic Health Inc's Sales TTM	$ 442 Millions	Visit GHDX's Income Statement
Sources of GHDX's Revenues		Visit GHDX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GHDX's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GHDX's Growth Rates	GHDX's Roa	GHDX's Inventory Turnover Ratio	GHDX's Dividend Comparisons
GHDX's Profitability Ratios	GHDX's Roi	GHDX's Asset Turnover Ratio	GHDX's Dividend Growth
GHDX's Valuation Ratios	GHDX's Roe	GHDX's Financial Strength Ratios	GHDX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2019	Receivable at quarter ending Sep 30 2019
Tearlab Corp	20.98	$ 22.997 Millions	$ 1.096 Millions
Fibrocell Science, Inc.	20.74	$ 24.528 Millions	$ 1.182 Millions
Momenta Pharmaceuticals inc	20.58	$ 58.508 Millions	$ 2.843 Millions
Uniqure N v	19.31	$ 7.054 Millions	$ 0.365 Millions
Wearable Health Solutions, Inc.	19.01	$ 0.903 Millions	$ 0.048 Millions
Lexicon Pharmaceuticals Inc	18.17	$ 330.417 Millions	$ 18.184 Millions
Immunogen inc	17.26	$ 52.250 Millions	$ 3.028 Millions
Fresenius Medical Care Ag	17.05	$ 30,991.056 Millions	$ 1,817.246 Millions
Axim Biotechnologies Inc	16.86	$ 0.680 Millions	$ 0.040 Millions
Aveo Pharmaceuticals Inc	16.41	$ 29.947 Millions	$ 1.825 Millions
Acadia Healthcare Company Inc	16.31	$ 5,490.769 Millions	$ 336.663 Millions
Vtv Therapeutics Inc	15.89	$ 7.279 Millions	$ 0.458 Millions
Therapeutic Solutions International Inc	15.46	$ 0.021 Millions	$ 0.001 Millions
Chemed Corporation	15.31	$ 1,873.739 Millions	$ 122.418 Millions
Cv Sciences Inc	15.28	$ 58.592 Millions	$ 3.835 Millions
Seres Therapeutics Inc	15.02	$ 37.512 Millions	$ 2.497 Millions
Mannkind Corporation	14.98	$ 63.076 Millions	$ 4.211 Millions
Kyntra Bio Inc	14.96	$ 356.657 Millions	$ 23.846 Millions
Ainos Inc	14.72	$ 0.015 Millions	$ 0.001 Millions
Geovax Labs Inc	14.67	$ 1.649 Millions	$ 0.112 Millions
Plx Pharma Inc	14.55	$ 0.829 Millions	$ 0.057 Millions
Corcept Therapeutics Inc	14.45	$ 285.422 Millions	$ 19.746 Millions
Jrsis Health Care Corp	14.41	$ 30.719 Millions	$ 2.132 Millions
Neurometrix Inc	13.67	$ 11.294 Millions	$ 0.826 Millions
Regeneron Pharmaceuticals Inc	13.65	$ 7,729.046 Millions	$ 566.075 Millions
Musclepharm Corporation	13.63	$ 82.413 Millions	$ 6.048 Millions
Verastem Inc	13.51	$ 15.049 Millions	$ 1.114 Millions
Bespoke Extracts Inc	13.03	$ 0.062 Millions	$ 0.005 Millions
Emmaus Life Sciences Inc	12.96	$ 7.458 Millions	$ 0.575 Millions
Otonomy Inc	12.83	$ 0.715 Millions	$ 0.056 Millions

Date modified: 2026-08-29T17:19:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.